<qa>  What is a multicenter, randomized, double-blind, placebo-controlled doseThis is a multicenter, randomized, double-blind, placebo-controlled dose-finding phase 2 trial to evaluate the efficacy and safety of YH12852 in patients with functional dyspepsia. 